Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT

NCT03256071 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation
Conditioning

Interventions

DRUG: Decitabine plus Modified BUCY
DRUG: Modified BUCY

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]